Aprea Therapeutics, Inc. (APRE) KPIs and segments
APRENasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.45+0.05 (+11.52%)
Close on Nov 17, 2026Market cap $5.71MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Aprea Therapeutics's business
Coming soon
This tab will track the numbers specific to Aprea Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?